2020 加拿大指南:结直肠癌腹膜转移的管理

2020-12-27 国外肿瘤科相关专家小组(统称) Curr Oncol . 2020 Dec;27(6):e621-e631.

结直肠癌腹膜转移的现代治疗是以细胞减灭术、全身化疗和腹腔热化疗为基础的。本文主要针对结直肠癌腹膜转移的管理提供了最新的实用方法。

中文标题:

2020 加拿大指南:结直肠癌腹膜转移的管理

英文标题:

Canadian guidelines on the management of colorectal peritoneal metastases

发布日期:

2020-12-27

简要介绍:

结直肠癌腹膜转移的现代治疗是以细胞减灭术、全身化疗和腹腔热化疗为基础的。本文主要针对结直肠癌腹膜转移的管理提供了最新的实用方法。

 

相关资料下载:
[AttachmentFileName(sort=1, fileName=2020 加拿大指南:结直肠癌腹膜转移的管理.pdf)] GetToolGuiderByIdResponse(projectId=1, id=263a31c002036e6c, title=2020 加拿大指南:结直肠癌腹膜转移的管理, enTitle=Canadian guidelines on the management of colorectal peritoneal metastases, guiderFrom=Curr Oncol . 2020 Dec;27(6):e621-e631., authorId=0, author=, summary=结直肠癌腹膜转移的现代治疗是以细胞减灭术、全身化疗和腹腔热化疗为基础的。本文主要针对结直肠癌腹膜转移的管理提供了最新的实用方法。, cover=https://img.medsci.cn/2021111/1610378742313_2020535.jpg, journalId=0, articlesId=null, associationId=887, associationName=国外肿瘤科相关专家小组(统称), associationIntro=null, copyright=0, guiderPublishedTime=Sun Dec 27 00:00:00 CST 2020, originalUrl=, linkOutUrl=, content=<div class="one_info2" style="color: #373737;"> <div id="all_content"> <div class="editor_mirror editor_mirror_del"> <p>结直肠癌腹膜转移的现代治疗是以细胞减灭术、全身化疗和腹腔热化疗为基础的。本文主要针对结直肠癌腹膜转移的管理提供了最新的实用方法。</p> </div> </div> </div> <div class="box_info" style="color: #373737;">&nbsp;</div>, tagList=[TagDto(tagId=539, tagName=结直肠癌)], categoryList=[CategoryDto(categoryId=5, categoryName=肿瘤科, tenant=100), CategoryDto(categoryId=76, categoryName=胃肠外科, tenant=100), CategoryDto(categoryId=85, categoryName=指南&解读, tenant=100), CategoryDto(categoryId=20620, categoryName=肿瘤医学网, tenant=100), CategoryDto(categoryId=21100, categoryName=达仁堂循证e学界, tenant=100)], articleKeywordId=0, articleKeyword=, articleKeywordNum=6, guiderKeywordId=539, guiderKeyword=结直肠癌, guiderKeywordNum=6, haveAttachments=1, attachmentList=null, guiderType=0, guiderArea=指南, guiderLanguage=1, guiderRegion=4, opened=0, paymentType=, paymentAmount=10, recommend=0, recommendEndTime=null, sticky=0, stickyEndTime=null, allHits=5102, appHits=98, showAppHits=0, pcHits=507, showPcHits=5004, likes=3, shares=12, comments=5, approvalStatus=1, publishedTime=Tue Jan 12 19:40:43 CST 2021, publishedTimeString=2020-12-27, pcVisible=1, appVisible=1, editorId=2020535, editor=qiushida2, waterMark=0, formatted=0, memberCards=[], isPrivilege=0, deleted=0, version=2, createdBy=null, createdName=qiushida2, createdTime=Mon Jan 11 23:25:54 CST 2021, updatedBy=2020535, updatedName=qiushida2, updatedTime=Sat Jan 06 16:50:33 CST 2024, courseDetails=[], otherVersionGuiders=[], isGuiderMember=false, ipAttribution=, attachmentFileNameList=[AttachmentFileName(sort=1, fileName=2020 加拿大指南:结直肠癌腹膜转移的管理.pdf)])
2020 加拿大指南:结直肠癌腹膜转移的管理.pdf
下载请点击:
评论区 (4)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=999247, encodeId=d75499924e14, content=学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=85, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210705/da99a5ddc5244395987d88047354dfa2/60de296e27ab48cdbea6b0cd416ada5f.jpg, createdBy=6c8d1668804, createdName=粪兜小医生, createdTime=Tue Jul 13 23:23:25 CST 2021, time=2021-07-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=956903, encodeId=faad95690334, content=学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=75, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/09/06/ce0813625e59b0ea3d4d7a1d217a17aa.jpg, createdBy=c07f5181118, createdName=看书学习听课, createdTime=Wed Apr 14 14:03:04 CST 2021, time=2021-04-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=917322, encodeId=818991e32266, content=学习了,受益匪浅, beContent=null, objectType=guider, channel=null, level=null, likeNumber=87, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=9d015255045, createdName=147ed5e4m67暂无昵称, createdTime=Sun Jan 17 08:34:18 CST 2021, time=2021-01-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=917193, encodeId=443a91e1930d, content=学习了,受益匪浅。, beContent=null, objectType=guider, channel=null, level=null, likeNumber=100, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=5c3c5448089, createdName=ms7000000496107358, createdTime=Sat Jan 16 17:55:21 CST 2021, time=2021-01-16, status=1, ipAttribution=)]
    2021-07-13 粪兜小医生

    学习

    0

  2. [GetPortalCommentsPageByObjectIdResponse(id=999247, encodeId=d75499924e14, content=学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=85, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210705/da99a5ddc5244395987d88047354dfa2/60de296e27ab48cdbea6b0cd416ada5f.jpg, createdBy=6c8d1668804, createdName=粪兜小医生, createdTime=Tue Jul 13 23:23:25 CST 2021, time=2021-07-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=956903, encodeId=faad95690334, content=学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=75, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/09/06/ce0813625e59b0ea3d4d7a1d217a17aa.jpg, createdBy=c07f5181118, createdName=看书学习听课, createdTime=Wed Apr 14 14:03:04 CST 2021, time=2021-04-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=917322, encodeId=818991e32266, content=学习了,受益匪浅, beContent=null, objectType=guider, channel=null, level=null, likeNumber=87, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=9d015255045, createdName=147ed5e4m67暂无昵称, createdTime=Sun Jan 17 08:34:18 CST 2021, time=2021-01-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=917193, encodeId=443a91e1930d, content=学习了,受益匪浅。, beContent=null, objectType=guider, channel=null, level=null, likeNumber=100, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=5c3c5448089, createdName=ms7000000496107358, createdTime=Sat Jan 16 17:55:21 CST 2021, time=2021-01-16, status=1, ipAttribution=)]
    2021-04-14 看书学习听课

    学习

    0

  3. [GetPortalCommentsPageByObjectIdResponse(id=999247, encodeId=d75499924e14, content=学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=85, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210705/da99a5ddc5244395987d88047354dfa2/60de296e27ab48cdbea6b0cd416ada5f.jpg, createdBy=6c8d1668804, createdName=粪兜小医生, createdTime=Tue Jul 13 23:23:25 CST 2021, time=2021-07-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=956903, encodeId=faad95690334, content=学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=75, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/09/06/ce0813625e59b0ea3d4d7a1d217a17aa.jpg, createdBy=c07f5181118, createdName=看书学习听课, createdTime=Wed Apr 14 14:03:04 CST 2021, time=2021-04-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=917322, encodeId=818991e32266, content=学习了,受益匪浅, beContent=null, objectType=guider, channel=null, level=null, likeNumber=87, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=9d015255045, createdName=147ed5e4m67暂无昵称, createdTime=Sun Jan 17 08:34:18 CST 2021, time=2021-01-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=917193, encodeId=443a91e1930d, content=学习了,受益匪浅。, beContent=null, objectType=guider, channel=null, level=null, likeNumber=100, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=5c3c5448089, createdName=ms7000000496107358, createdTime=Sat Jan 16 17:55:21 CST 2021, time=2021-01-16, status=1, ipAttribution=)]
    2021-01-17 147ed5e4m67暂无昵称

    学习了,受益匪浅

    0

  4. [GetPortalCommentsPageByObjectIdResponse(id=999247, encodeId=d75499924e14, content=学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=85, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210705/da99a5ddc5244395987d88047354dfa2/60de296e27ab48cdbea6b0cd416ada5f.jpg, createdBy=6c8d1668804, createdName=粪兜小医生, createdTime=Tue Jul 13 23:23:25 CST 2021, time=2021-07-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=956903, encodeId=faad95690334, content=学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=75, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/09/06/ce0813625e59b0ea3d4d7a1d217a17aa.jpg, createdBy=c07f5181118, createdName=看书学习听课, createdTime=Wed Apr 14 14:03:04 CST 2021, time=2021-04-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=917322, encodeId=818991e32266, content=学习了,受益匪浅, beContent=null, objectType=guider, channel=null, level=null, likeNumber=87, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=9d015255045, createdName=147ed5e4m67暂无昵称, createdTime=Sun Jan 17 08:34:18 CST 2021, time=2021-01-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=917193, encodeId=443a91e1930d, content=学习了,受益匪浅。, beContent=null, objectType=guider, channel=null, level=null, likeNumber=100, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=5c3c5448089, createdName=ms7000000496107358, createdTime=Sat Jan 16 17:55:21 CST 2021, time=2021-01-16, status=1, ipAttribution=)]
    2021-01-16 ms7000000496107358

    学习了,受益匪浅。

    0

拓展阅读

2010 BSG 中高危人群结直肠癌筛查与监测指南

英国胃肠病学会(BSG,British Society of Gastroenterology) · 2010-05-01

2010 结直肠癌肝转移诊断和综合治疗指南(V 2010)

中华医学会外科学分会 · 2010-06-01

2011 NICE 结直肠癌诊疗指南

英国国家卫生与临床优化研究所(NICE,National Institute for Health and Clinical Excellence) · 2011-01-01

2011NICE 结直肠癌高危人群(溃疡性结肠炎、克罗恩病、结直肠腺瘤患者)结肠镜监测指南

英国国家卫生与临床优化研究所(NICE,National Institute for Health and Clinical Excellence) · 2011-03-23

2011 规范结直肠癌术中缓释型氟尿嘧啶腹腔内化疗的专家共识

结直肠癌术中缓释型氟尿嘧啶腹腔内化疗共识专家组 · 2011-06-01

结直肠癌诊疗规范(2010年版)

中华人民共和国卫生部(MINISTRY OF HEALTH OF THE PEOPLE`S REPUBLIC OF CHINA) · 2011-12-20